Dalian Yalifeng Biopharmaceutical

Dalian Yalifeng Biopharmaceutical is a prominent Chinese vaccine manufacturer and a key subsidiary of Fosun Pharma. Founded in 2002 and headquartered in Dalian, the company focuses on the development and commercialization of high-quality human vaccines. Its core product offerings include split-virion influenza vaccines, Vero cell-based rabies vaccines, and live attenuated mumps vaccines. The company operates advanced GMP-certified manufacturing facilities and contributes significantly to the domestic supply of essential immunizations in China. Yalifeng continues to expand its pipeline with next-generation products, such as quadrivalent influenza vaccines, to address evolving public health needs.